EUSOBI 2025

In the fight against breast cancer, we have achieved a lot. However, challenges remain: 1 in 8 breast cancers is still missed¹, 50% of women receiving annual mammograms experience false-positive results², and there is a significant shortage of radiologists and technologists to meet the growing demand for breast cancer screening and diagnosis.³ Our ambition is to change that — and to be your partner in delivering a more personalized approach to breast cancer diagnostics. Accurate imaging is essential for effective, individualized treatment.

At this year’s European Society of Breast Imaging, we will showcase the latest innovations in breast imaging tailored to each patient’s needs:

• Fast, wide-angle DBT enabling 43% increased detection of invasive cancers⁴ and significant reduction of interval cancers when introduced in screening⁵
• CEM for significant increased detection of invasive cancers when introduced in BC surveillance⁶
• 40% faster and 2x higher resolution MRI with AI-powered reconstruction⁷
• Better lesion characterization with next-generation 2D SWE and its improved lesion deliniation⁸
• AI solution for signifcantly reduced reading time in tomosynthesis⁵ and 44% reduced reading workload in 2D (compared to double-reading)⁹

Visit our clinical sessions and come to our booth to experience how these latest advancements in breast imaging can support you for faster and more confident treatment decisions.